We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$254B
AUM Growth
+$235B
Cap. Flow
+$230B
Cap. Flow %
90.52%
Top 10 Hldgs %
17.14%
Holding
3,268
New
2,228
Increased
916
Reduced
59
Closed
11

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$8.24B
2
AAPL icon
Apple
AAPL
+$6.76B
3
AMZN icon
Amazon
AMZN
+$6.52B
4
META icon
Meta Platforms (Facebook)
META
+$4.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.45B

Sector Composition

Rank Sector Weight
1 Technology 18.97%
2 Financials 14.46%
3 Healthcare 12.78%
4 Consumer Discretionary 10.65%
5 Industrials 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VHC icon
2601
VirnetX Holding Corp
VHC
$63.1M
$1.39M ﹤0.01%
+11,224
New +$1.4M
NVEC icon
2602
NVE Corp
NVEC
$609M
$1.39M ﹤0.01%
+19,999
New +$1.67M
ZEUS
2603
DELISTED
Olympic Steel
ZEUS
$1.39M ﹤0.01%
+101,925
New +$1.52M
CSLT
2604
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.39M ﹤0.01%
+430,698
New +$1.48M
FF icon
2605
Future Fuel
FF
$223M
$1.39M ﹤0.01%
+118,819
New +$1.48M
LPG icon
2606
Dorian LPG
LPG
$1.96B
$1.39M ﹤0.01%
+153,607
New +$1.22M
ASND icon
2607
Ascendis Pharma A/S
ASND
$16.8B
$1.38M ﹤0.01%
12,015
+8,568
+249% +$1.03M
TRC icon
2608
Tejon Ranch
TRC
$451M
$1.37M ﹤0.01%
+82,816
New +$1.41M
KALV
2609
DELISTED
KalVista Pharmaceuticals
KALV
$1.37M ﹤0.01%
+61,906
New +$1.45M
MRNA icon
2610
Moderna
MRNA
$23.6B
$1.37M ﹤0.01%
+93,744
New +$2.01M
CALX icon
2611
Calix
CALX
$2.39B
$1.37M ﹤0.01%
+208,525
New +$1.41M
SLP icon
2612
Simulations Plus
SLP
$371M
$1.37M ﹤0.01%
+47,872
New +$1.16M
TH icon
2613
Target Hospitality
TH
$1.64B
$1.36M ﹤0.01%
+149,587
New +$1.51M
MOFG
2614
DELISTED
MidWestOne Financial Group
MOFG
$1.36M ﹤0.01%
+48,629
New +$1.38M
PAR icon
2615
PAR Technology
PAR
$735M
$1.36M ﹤0.01%
+48,207
New +$1.24M
EIGI
2616
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$1.36M ﹤0.01%
+282,531
New +$1.53M
SIBN icon
2617
SI-BONE Inc
SIBN
$834M
$1.34M ﹤0.01%
+66,126
New +$1.14M
NBEV
2618
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$1.34M ﹤0.01%
+288,211
New +$1.48M
CYCN icon
2619
Cyclerion Therapeutics
CYCN
$16.7M
$1.34M ﹤0.01%
+5,854
New +$1.66M
OPCH icon
2620
Option Care Health
OPCH
$3.56B
$1.34M ﹤0.01%
+128,935
New +$1.05M
NSSC icon
2621
Napco Security Technologies
NSSC
$1.48B
$1.34M ﹤0.01%
+90,246
New +$1.2M
INO icon
2622
Inovio Pharmaceuticals
INO
$69M
$1.33M ﹤0.01%
+37,806
New +$1.5M
SCZ icon
2623
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
$1.33M ﹤0.01%
23,200
+17,200
+287% +$993K
PCMI
2624
DELISTED
PCM, Inc
PCMI
$1.32M ﹤0.01%
+37,618
New +$1.11M
PETS icon
2625
PetMed Express
PETS
$42.3M
$1.31M ﹤0.01%
+83,739
New +$1.65M

Similar funds

Nuveen's Q2 2019 Portfolio in Review

As of Q2 2019, Nuveen held 3,268 positions worth $254B, up 1,256% from $18.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Nuveen deployed $230B of net new capital in Q2 2019, opening 2,228 new positions and adding to 916 existing holdings. Its largest new stake was Netflix: 33,941,080 shares worth $1.25B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $142M trimmed.

  • Nuveen's largest Q2 2019 buy was Netflix: 33,941,080 shares worth $1.25B.
  • Nuveen added most to Microsoft in Q2 2019, an estimated $8.24B increase.
  • Nuveen's biggest Q2 2019 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $142M.
  • Nuveen fully exited Nuveen ESG Large-Cap Value ETF in Q2 2019, selling an estimated $22M.
  • Nuveen's ten largest holdings make up 17% of its $254B portfolio in Q2 2019.
  • Nuveen opened 2,228 new positions and closed 11 in Q2 2019.
  • Nuveen's portfolio value rose 1,256% quarter-over-quarter to $254B.

Based on Nuveen's 13F filing for Q2 2019, filed 15 Aug 2019.